| Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center. | |
| | |
MedLine Citation:
|
PMID: 20216277 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: The aim of this study was to examine the association of vasomotor symptoms (VMS) with anxiety and/or depressive symptoms in perimenopausal women. METHODS: A retrospective chart review of 487 women 40 to 64 years old seen during October 2004 to December 2006 in the Women's Midlife Assessment Program at the University of California, Davis, was performed. Of these, 395 women were included in the analysis: 58 (15%) were premenopausal, 199 (50%) were perimenopausal, and 138 (35%) were postmenopausal. VMS bothersomeness was represented by converting Likert-scale ratings for hot flashes and night sweats to scores and adding them into an overall score. Multiple logistic regression models were used to quantify the association of self-reported anxiety and/or depressive symptoms with VMS bothersomeness. RESULTS: Thirty-one (53%) premenopausal, 131 (66%) perimenopausal, and 69 (50%) postmenopausal women reported anxiety and/or depressive symptoms. Perimenopausal and postmenopausal women reporting anxiety and/or depressive symptoms had significantly higher VMS bothersomeness scores (2.2 +/- 1.7 and 2.2 +/- 1.9, respectively) than did women who did not report these symptoms (1.7 +/- 1.7 and 1.6 +/- 1.7, respectively; both P values < 0.05). Women experiencing more bothersome VMS were significantly more likely to report anxiety and/or depressive symptoms (odds ratio, 1.5; P < 0.01). Perimenopausal women were significantly more likely to report anxiety and/or depressive symptoms than were postmenopausal women (odds ratio, 1.9; P < 0.01). Both associations remained significant after restricting the analyses to women not taking hormone therapy or psychotropics. CONCLUSIONS: VMS bothersomeness was associated with self-reported anxiety and/or depressive symptoms, showing the importance of screening for anxiety and mood changes during perimenopause. |
| | |
Authors:
|
Andreea L Seritan; Ana-Maria Iosif; Ju Hui Park; Deborah DeatherageHand; Richard L Sweet; Ellen B Gold |
Related Documents
:
|
11291187 - Schizoid anxiety: a reappraisal of the manic defense and the depressive position. 2565767 - Alpidem, a novel anxiolytic drug. a double-blind, placebo-controlled study in anxious o... 1792557 - Observer bias in the assessment of anxiety and depression. 18779777 - Psychometric evaluation of a patient-rated troubling symptom scale for generalized anxi... 21746717 - Simulation in pediatrics: the reliability and validity of a multiscenario assessment. 17214717 - Clinical study with allogeneic cultured dermal substitutes for chronic leg ulcers. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Menopause (New York, N.Y.) Volume: 17 ISSN: 1530-0374 ISO Abbreviation: Menopause Publication Date: 2010 Mar |
Date Detail:
|
Created Date: 2010-03-10 Completed Date: 2010-04-16 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9433353 Medline TA: Menopause Country: United States |
Other Details:
|
Languages: eng Pagination: 410-5 Citation Subset: IM |
Affiliation:
|
Department of Psychiatry and Behavioral Sciences, University of California, Davis, Medical Center, Sacramento, CA, USA. andreea.seritan@ucdmc.ucdavis.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Cross-Sectional Studies Depression / epidemiology, psychology* Female Hot Flashes / epidemiology, psychology* Humans Logistic Models Middle Aged Perimenopause / physiology*, psychology* Questionnaires Retrospective Studies Socioeconomic Factors Sweating* / physiology Vasomotor System / physiopathology* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Soy isoflavones, Mediterranean diet, and physical exercise in postmenopausal women with insulin resi...
Next Document: Bone mineral density after concurrent chemoradiation in patients with uterine cervical cancer.